Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03275103 |
|---|---|
| Brief Title: | Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) |
| First Submitted : | September 5, 2017 |
| First Submitted that Met QC Criteria : | September 5, 2017 |
| First Posted : | September 7, 2017 |
| Last Update Submitted that Met QC Criteria : | April 3, 2024 |
| Last Update Posted : | April 4, 2024 |